Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT06337019
Recruiting Observational

The Italian Registry of Malnutrition in Oncology

NCT06337019 · tracked via the Priya Life Science Italy tracker
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase
Observational
Started
2022-10-25
Last updated
2024-04-03

Condition(s) studied

CancerCancer Metastatic

Investigational drug(s) / intervention(s)

Cohort observational

Cohort observational: Cohort observational

Study summary

The aim of the Italian Registry of Malnutrition in Oncology (IRMO) is to set up a digital register of newly diagnosed or treated oncologic patients to monitor their nutritional status, early identify malnutrition and investigate the implications of nutritional support management. In particular, this project aims to establish a prospective cohort of cancer patients in order to investigate the effects of nutritional status and management on overall survival (OS) and progression free survival (PFS), and analyse the effects of the nutritional management and support on patients' symptoms and QoL.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged ≥18 years; * New diagnosis of the following cancers: head and neck, oesophagus/stomach, colorectal, hepato-biliary, pancreatic, lung, prostate, other urogenital, breast, gynaecological and, soft tissue sarcomas and melanomas; patients with a new diagnosis of metastatic disease will be also included; * Eligible for active treatment; * Written informed consent to participate in the study. Exclusion Criteria: * Impossibility to undertake the expected measurements; * Impossibility to guarantee the attendance of the follow-up visits.

Primary outcome measure(s)

  • Overall survival — 1 year
    Percentage of patients who are alive.

Trial sites (16)

FacilityCityRegionStatus
IRCCS Istituto Tumori Giovanni Paolo II, Bari BA Not Yet Recruiting
IRCCS Saverio De Bellis Castellana Grotte BA Recruiting
Istituto Ortopedico Rizzoli Bologna BO Recruiting
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRCCS Meldola FC Recruiting
IRCCS Ospedale Policlinico San Martino Genova GE Not Yet Recruiting
IRCCS Ospedale San Raffaele, Milano Milan MI Recruiting
Centro di Riferimento Oncologico Aviano PN Recruiting
IOV Istituto Oncologico Veneto Padova PV Recruiting
AUSL IRCCS Reggio-Emilia Reggio Emilia RE Recruiting
IDI IRCCS - Istituto Dermopatico dell'Immacolata Roma RM Recruiting
Istituto Nazionale Tumori Regina Elena Roma RM Recruiting
Policlinico Universitario Agostino Gemelli Roma RM Recruiting
Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS Candiolo TO Recruiting
IRCCS Sacro Cuore Don Calabria Negrar VR Recruiting
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples Italy Not Yet Recruiting
Fondazione IRCCS Policlinico San Matteo, Pavia Pavia Italy Recruiting

More Fondazione IRCCS Policlinico San Matteo di Pavia trials in Italy

Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults Recruiting
An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy Recruiting
Inflammation, Autoimmunity and Healthy Ageing in Menopause Transition. An Observational, Cross-sectional Study Starting soon
Local Registry of Primary Cutaneous T-cell Lymphomas Recruiting
CHOLE-POSSUM PRO Validation for Prediction of Mortality After Cholecystectomy for Acute Calculous Cholecystitis: Protocol for a Prospective Multicenter Observational Study Recruiting

Other trials for the same condition

Study of IMC-P115C in Advanced PRAME-Positive Cancers Recruiting
Met Non Small Cell Cancer Registry (MOMENT) Recruiting
Longitudinal Registry Including Patients Treated With Heavy Particles Recruiting
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe Recruiting
Diagnostic Performance of PET/CT-PSMA in Patients With Non-prostatic PSMA-expressing Neoplasms Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06337019 on ClinicalTrials.gov ↗ ← All trials in Italy